Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease. [PDF]
Moghekar AR +17 more
europepmc +1 more source
Molecular Modeling of Single Beta-Sheet and the Beta-Sheet Stack of Amyloid Beta Protein 25 – 35
Amiloidosis is the misfolding of soluble proteins followed by their self-assembling, resulting in aggregation into insoluble fibrils which replace the functional cells or block the connectivity between the cells.
segalen, Victor +3 more
core
Oropharyngeal dysphagia and amyloid beta pathology in the TgF344-AD rat model of Alzheimer's disease. [PDF]
Cullins MJ +7 more
europepmc +1 more source
Progress in Optical Methods for the Detection of Two Core Blood Biomarkers of Alzheimer's Disease: Amyloid-Beta and Tau Proteins. [PDF]
Xia N, Gao F, Zheng C.
europepmc +1 more source
Analytical framing of Amyloid beta monoclonal antibody trials in Alzheimer's disease can obscure clinical effects. [PDF]
Tijms BM +4 more
europepmc +1 more source
Fisetin Attenuates Amyloid-Beta-Induced Neurotoxicity in Human Neuroblastoma SH-SY5Y Cells: Integrating In Silico Target Prediction and In Vitro Validation. [PDF]
Jaiswal C, Singh I, Singh AK.
europepmc +1 more source
Theranostic Nanoparticles for Fluorosensitive Visualization and Inhibition of Amyloid Beta-Induced Neuroinflammation. [PDF]
Tamima U +9 more
europepmc +1 more source
Potential correlation between chronic pain and amyloid beta in Alzheimer's disease. [PDF]
Liu Y, Wang XP.
europepmc +1 more source
Elucidating the neuropathological and molecular heterogeneity of amyloid beta and tau in Alzheimer's disease through machine learning and transcriptomic integration. [PDF]
Zhao K +10 more
europepmc +1 more source
Methylomic signatures of tau and amyloid-beta in transgenic mouse models of Alzheimer's disease neuropathology. [PDF]
Leung SK +12 more
europepmc +1 more source

